M. Ronden

Brief Report on Radiological Changes following Stereotactic Ablative Radiotherapy (SABR) for Early-Stage Lung Tumors: A Pictorial Essay

M. Ronden, David A. Palma, Ben J. Slotman et al. · Journal of Thoracic Oncology · 2018 · 31 citations · Full text

Medicine, Oncology, Radiology +13

Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer

M. Ronden, John R. van Sörnsen de Koste, Carol Johnson et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 30 citations

Medicine, Oncology, Radiology +14

The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis

M. Ronden, Idris Bahce, Niels Claessens et al. · JTO Clinical and Research Reports · 2021 · 22 citations · Full text

Medicine, Oncology, Immunotherapy +16

Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer

M. Ronden, Idris Bahce, Sayed M.S. Hashemi et al. · Lung Cancer · 2020 · 17 citations

Medicine, Oncology, Surgery +11

Stereotactic ablative radiotherapy in patients with early-stage non-small cell lung cancer and co-existing interstitial lung disease

Tobias Finazzi, M. Ronden, F. Spoelstra et al. · Acta Oncologica · 2020 · 14 citations · Full text

Medicine, Oncology, Radiation Oncology +9